A Review on process validation of solid dosage form
Abstract
Objective: The purpose of this work is to perform a study on concurrent validation of levonorgestrel tablet BP 0.03mg that will deliver process validation approach as a quality assurance means. The process validation program will be investigated so that the plan will be designed to the character of the procedure under study. This can be performed by checking and controlling the various critical in process parameters.
Method: The samples from the three consecutive batches of levonorgestrel tablet 0.03mg are collected at the different stages of the manufacturing from dispensing, mixing, granulation process, drying process, blending process, compression process. Each and every parameter are analyzed and tested as per the specifications and all the data are recorded. The obtained results must be within the specified limit range.
Result: The results obtained from the evaluation of different parameters like bulk density, tapped density, friability, hardness, weight variation, and assay were found to be within specification limit range.
Conclusion: The conclusion of the concurrent process validation of levonorgestrel tablet BP 0.03mg is based on the result of the validation data of three consecutive batches. It is concluded that the manufacturing process used for levonorgestrel consistently producing the stable product meeting it is predetermined specification and quality attributes.
Keywords: Concurrent process validation, Process validation, Levonorgestrel, Critical process parameter.
Keywords:
Concurrent process validation, Process validation, Levonorgestrel, Critical process parameterDOI
https://doi.org/10.22270/jddt.v11i4.4880References
Maurya J, "Roll of process validation in pharmaceutical industry." J. Harmo. Res.Pharm.2013; 2(3):151-172.
Katz P & Campbell C, "Process Validation Guidance: process validation Revisited." J. GXP comp.2012; 16(4):18-29.
Huber L., validation and qualification in Analytical Laboratories; 2nd Edn; Informa Healthcare USA Inc, NEW YORK, 2007, pp 25-3. https://doi.org/10.3109/9780849382680
Tandel J, Dedania Z & Vadalia K, "Review on Process Validation of Pyrazinamide Tablets." Int. J. of Advances in Pharm. Bio. & Chem, 2012; 1(3):342-353.
Quality Management System - Process Validation Guidence, 2nd edition,2004, 1-36.
Kathiresan K, Moorthi C, Prathyusha Y, Gade B, Reddy B & Manavalan R, "An overview of pharmaceutical validation." Res. J. of Pharma. Bio. & Chem. Sci. 2010; 1(4):1026-1035.
Guideline for Process validation of pharmaceutical dosage form- Saudi Food & Drug Authority, Version 2.1, August 2010.
Mohammed SA, "Pharmaceutical Process Validation: An Overview." J.Adv.Pharm. Edu. Res.2012; 2(4):186-200.
Mahar P, Verma A, "Pharmaceutical process validation: an overview." Int.J. Pharm. Res. Bio-Sci.2014; 3(4):243-262.
Robert A. Nash, Alfred H. Wachter. Pharmaceutical process validation; 3rd Edn; Marcel Dekker, Inc publication,2003, 1-23.
Banker GS., and Rhodes C. In Modern pharmaceutics; 4th Edn; marcel dekker Inc., New York, 2007, pp 15,659-665.
Jyakhwa U, Joshi D, Chikanbanjar N, "A Review Article on Concurrent Process Validation." Pharmaceutical Sciences.2020; 1(1):48-54.
Sandhya C, Bonthagarala B, "Process validation: An essential process in Pharmaceutical industry." Int. J. adv. In scientific Res.2015; 1(4):179-182. https://doi.org/10.7439/ijasr.v1i4.1781
Patel B, Patel M, Chaudhary A. A Comprehensive and Comparative Study on Regulations of Medical Countermeasures in USA and INDIA. International Journal of Emerging Technologies and Innovative. 2019; 6(5):289-304.
Patel VK, "Process Validation: An Essential Process in Pharmaceutical Industry." Pharma. Info. 2010; 1:1-21.
Alam S,"Pharmaceutical Process Validation & its tools an Overview."J. Adv. pharma Edu&Res.2012, 25-35.
Agalloco J., and Frederick J. In Validation of pharmaceutical process; 3rd Edn; informa healthcare, New York, 2008, pp 1-24,445.
Patel DM, Chaudhary AB and Patel BD. Development and validation of RP-HPLC method for simultaneous estimation Beclomethasone Dipropionate, Phenylephrine Hydrochloride and Lignocaine Hydrochloride in cream. World Journal of Pharmacy and Pharmaceutical Sciences. 2018; 7(5):829-841.
Rathore A.S, Noferi J.F, Arling E.R, Sofer G, Walter P, and O' Leary R, "Process validation how much to do and when to do it", Biopharm, 2002, pp. 18-28.
Trivedi DG, Chaudhary AB and Patel BD. Method Development and Validation for Estimation of Clotrimazole, Fusidic acid and Mometasone Furoate in Cream by RP-HPLC, World Journal of Pharmacy and Pharmaceutical Sciences. 2017; 6(5):1204-1219. https://doi.org/10.20959/wjpps20175-9173
Health Canada / Health Products and Food branch inspectorate, validation guidelines for pharmaceutical dosage forms (GUI-0029)/ December, 2009.
Published
Abstract Display: 942 
PDF Downloads: 732 PDF Downloads: 423 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.